Cite
HARVARD Citation
Clark, K. et al. (n.d.). P153 Tocilizumab in systemic sclerosis: real world experience from a single centre cohort supports potential benefit on lung function for anti-topoisomerase (Scl-70) positive subgroup. Rheumatology. p. . [Online].